Pictet Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $39.2M | Buy |
501,560
+39,044
| +8% | +$3.05M | 0.04% | 357 |
|
2025
Q1 | $33.5M | Buy |
462,516
+86,771
| +23% | +$6.29M | 0.04% | 380 |
|
2024
Q4 | $27.8M | Buy |
375,745
+26,573
| +8% | +$1.97M | 0.03% | 415 |
|
2024
Q3 | $23M | Buy |
349,172
+8,311
| +2% | +$548K | 0.03% | 455 |
|
2024
Q2 | $31.5M | Buy |
340,861
+5,135
| +2% | +$474K | 0.04% | 364 |
|
2024
Q1 | $32.1M | Sell |
335,726
-13,668
| -4% | -$1.31M | 0.03% | 384 |
|
2023
Q4 | $26.6M | Sell |
349,394
-628,357
| -64% | -$47.9M | 0.03% | 410 |
|
2023
Q3 | $67.7M | Buy |
+977,751
| New | +$67.7M | 0.08% | 237 |
|